Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 15, 1992Blood

Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor

View Full Paper
Ask AI
Bookmark
Share

Authors

CLCF LeMaistreCHRISTUS Transplant InstituteCMC MeneghettiMRMichael G. RosenblumJohns Hopkins University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

LeMaistre et al. (1992) studied this question.

synapsesocial.com/papers/6aa95a41f5c5d15e468fc99chttps://doi.org/10.1182/blood.v79.10.2547.bloodjournal79102547
View Full Paper
Ask AI
Bookmark
Share